Literature DB >> 10813151

Non-participation in a population-based seroprevalence study of vaccine-preventable diseases.

H E De Melker1, N J Nagelkerde, M A Conyn-van Spaendonck.   

Abstract

To estimate the immunity of the Dutch population against vaccine-preventable diseases, a population-based serum bank was established. Since a multi-tiered approach to enroll eligible individuals was used, both the overall non-response selection and the effect, on this selection, of including additional participants and of excluding a subgroup of non-participants (i.e. those without questionnaire data) could be studied. For some characteristics associated with non-participation, an association with seroprevalence of vaccine-preventable diseases is likely (e.g. age, gender). For other characteristics (e.g. marital status, receipt of reminder, degree of urbanization) the association with immune status is unclear but probably small. If the distribution in the population, or information on all participants and non-participants, of the characteristic is available, then the effect on the seroprevalence can be estimated. However, investigators have to be aware that studying only a subgroup of non-participants might lead to a biased insight into non-participation selection. Furthermore, merely including additional participants might not always reduce this bias.

Entities:  

Mesh:

Year:  2000        PMID: 10813151      PMCID: PMC2810909          DOI: 10.1017/s0950268899003234

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  6 in total

Review 1.  The role of seroepidemiology in the comprehensive surveillance of vaccine-preventable diseases.

Authors:  Sarah E Wilson; Shelley L Deeks; Todd F Hatchette; Natasha S Crowcroft
Journal:  CMAJ       Date:  2011-11-14       Impact factor: 8.262

Review 2.  Use of Pathogen-Specific Antibody Biomarkers to Estimate Waterborne Infections in Population-Based Settings.

Authors:  Natalie G Exum; Nora Pisanic; Douglas A Granger; Kellogg J Schwab; Barbara Detrick; Margaret Kosek; Andrey I Egorov; Shannon M Griffin; Christopher D Heaney
Journal:  Curr Environ Health Rep       Date:  2016-09

3.  Participation behavior of bladder cancer survivors in a medical follow-up survey on quality of life in France.

Authors:  Tomohiro Matsuda; Hélène Marche; Pascale Grosclaude; Serge Clement
Journal:  Eur J Epidemiol       Date:  2004       Impact factor: 8.082

4.  Seroprevalence of varicella-zoster virus and predictors for seronegativity in the Amsterdam adult population.

Authors:  Gini G C van Rijckevorsel; Marjolein Damen; Gerard J Sonder; Maarten F Schim van der Loeff; Anneke van den Hoek
Journal:  BMC Infect Dis       Date:  2012-06-21       Impact factor: 3.090

5.  Participation in and attitude towards the national immunization program in the Netherlands: data from population-based questionnaires.

Authors:  Liesbeth Mollema; Nancy Wijers; Susan J M Hahné; Fiona R M van der Klis; Hendriek C Boshuizen; Hester E de Melker
Journal:  BMC Public Health       Date:  2012-01-20       Impact factor: 3.295

6.  Herpes simplex virus type 1 and type 2 in the Netherlands: seroprevalence, risk factors and changes during a 12-year period.

Authors:  Petra J Woestenberg; Jeroen H T Tjhie; Hester E de Melker; Fiona R M van der Klis; Jan E A M van Bergen; Marianne A B van der Sande; Birgit H B van Benthem
Journal:  BMC Infect Dis       Date:  2016-08-02       Impact factor: 3.090

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.